Was Jim Cramer Right to Favor Another Stock Over Viking Therapeutics (VKTX)? [Yahoo! Finance]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
Back then, a humorous caller asked if they should “bulk up” on Viking Therapeutics, Inc. (NASDAQ:VKTX), referencing both weight loss drugs and football. Cramer responded with his trademark flair and a clear preference: “I even like the Vikings more than I like Viking Therapeutics — and that's saying something ‘cause they ain't that good. I say you need to be in Eli Lilly. Step your game up, partner.” A microbiologist in protective gear studying samples in a laboratory. Cramer favored Eli Lilly over Viking, and with VKTX down -52.27%, he made the better call. Viking Therapeutics, Inc. (NASDAQ:VKTX) is a clinical-stage biopharmaceutical company developing treatments for metabolic and endocrine disorders, including obesity and liver disease. Cramer remains firm in his opinion. Here's what he said on January 30 this year: “Okay, people, people think that even if Lily's stock can't go up, why would we want Viking Therapeutics? And a lot of people were in it for a takeover. So
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Viking Therapeutics, Inc. (VKTX) Outperforms Broader Market: What You Need to Know [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics to Report Financial Results for Second Quarter 2025 on July 23, 2025PR Newswire
- H.C. Wainwright Reiterates a Buy Rating on Viking Therapeutics (VKTX), Sets a $102 PT [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics, Inc. (VKTX) Rises Higher Than Market: Key Facts [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics: What's Next After GLP-1 Hype Dies Down And Competition Intensifies [Seeking Alpha]Seeking Alpha
VKTX
Earnings
- 4/23/25 - Miss
VKTX
Sec Filings
- 7/3/25 - Form 4
- 7/3/25 - Form 4
- 7/3/25 - Form 4
- VKTX's page on the SEC website